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Abstract
Background: Exposure to air pollution impairs aspects of pulmonary and autonomic function and causes
pulmonary inflammation. However, how exercising in air pollution affects these indices is poorly understood.
Therefore, the purpose of this study was to determine the effects of low-intensity and high-intensity cycling with
diesel exhaust (DE) exposure on pulmonary function, heart rate variability (HRV), fraction of exhaled nitric oxide
(FeNO), norepinephrine and symptoms.
Methods: Eighteen males performed 30-min trials of low-intensity or high-intensity cycling (30 and 60% of power
at VO2peak) or a resting control condition. For each subject, each trial was performed once breathing filtered air (FA)
and once breathing DE (300μg/m3 of PM2.5, six trials in total). Pulmonary function, FeNO, HRV, norepinephrine and
symptoms were measured prior to, immediately post, 1 h and 2 h post-exposure. Data were analyzed using
repeated-measures ANOVA.
Results: Throat and chest symptoms were significantly greater immediately following DE exposure than following
FA (p < 0.05). FeNO significantly increased 1 h following high-intensity exercise in DE (21.9 (2.4) vs. 19.3 (2.2) ppb)
and FA (22.7 (1.7) vs. 19.9 (1.4)); however, there were no differences between the exposure conditions. All HRV
indices significantly decreased following high-intensity exercise (p < 0.05) in DE and FA. The exception to this
pattern was LF (nu) and LF/HF ratio, which significantly increased following high-intensity exercise (p < 0.05). Plasma
norepinephrine (NE) significantly increased following high-intensity exercise in DE and FA, and this increase was
greater than following rest and low-intensity exercise (p < 0.05). DE exposure did not modify any effects of exercise
intensity on HRV or norepinephrine.
Conclusions: Healthy individuals may not experience greater acute pulmonary and autonomic effects from
exercising in DE compared to FA; therefore, it is unclear if such individuals will benefit from reducing vigorous
activity on days with high concentrations on particulate matter.
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Background
In healthy individuals, exercise causes bronchodilation [1]
and decreases the fraction of exhaled nitric oxide (FeNO),
which is a surrogate measure of pulmonary inflammation
[2]. In contrast, air pollution exposure that deposits par-
ticulate matter (PM) in the respiratory tree results in
pulmonary oxidative stress and an increase in bronchial
responsiveness, airway resistance, and airway inflamma-
tory cells [3, 4]. In susceptible populations [5], and some
healthy populations [6] such physiological changes due to
air pollution exposure can impair pulmonary function.
Despite the opposing effects of exercise alone and air
pollution exposure alone on pulmonary function and pul-
monary inflammation, it is unclear how exercise modifies
the pulmonary effects of air pollution.
Exposure to PM can also perturb the autonomic
nervous system, resulting in an increase in sympathetic,
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and a decrease in parasympathetic nervous system activ-
ity [7], with a concomitant increase in norepinephrine
levels in the paraventricular nucleus of the hypothal-
amus [8]. At the onset of physical activity, parasympa-
thetic activity decreases [9–15], which likely represents
the vagal withdrawal that occurs with physical activity or
exercise [16]. Following exercise, perturbations in auto-
nomic control return close to resting levels within 1 h
[17]. Diesel exhaust (DE) contains PM and exposure to
DE prior to exercise increases exercise heart rate and
attenuates exercise-induced bronchodilation [1]. There-
fore, it is possible that exposure to DE containing PM
during exercise could affect autonomic and pulmonary
function. However, there are no studies examining how
the effects of DE on the autonomic nervous system are
modified by exercise. Additionally, the studies directly
examining the effects of continuous exercise with expos-
ure to PM on pulmonary function, have led to inconsist-
ent findings [18–20]. As exercise protocol, duration, and
air pollution exposure characteristics vary, drawing
any robust conclusions on how exposure to air pollu-
tion during exercise affects pulmonary function or
inflammation is difficult.
When exercise intensity increases, minute ventilation
increases and the proportion of PM that deposits in the
respiratory tree increases [21–23], leading to a theoretical
increase in the dose of diesel exhaust particulate matter
(DPM). Therefore, one might expect that the magnitude
of physiological and health effects of air pollution would
be greater than during rest or lower intensity exercise.
Therefore, the purpose of this study was to determine the
effects of low- and high-intensity cycling on pulmonary
function, pulmonary inflammation, autonomic function
and symptoms of the throat/chest, nose and eyes. We hy-
pothesized that exposure to DE would impair pulmonary
function, increase the FeNO, plasma norepinephrine, and
subjective symptoms and alter autonomic nervous system
function (as measured by heart rate variability (HRV)).
We also hypothesized that any physiological effects of DE
would be magnified as exercise intensity increases.
Methods
Eighteen recreationally active males volunteered for the
study. Participants were considered recreationally active
and included in the study if they met Canada’s physical
activity guidelines of 150 min of moderate-to-vigorous
activity per week. Only males were studied because
FeNO is affected by sex hormones [24] that vary across
the menstrual cycle; given that the study required partic-
ipants to attend on seven occasions, testing in females
would have needed to have occurred over a 7-month
period, during which time activity levels and physio-
logical parameters could vary significantly leading to an
increase in variability of the data. Each participant was a
non-smoker and had no history of respiratory or cardio-
vascular disease. The Clinical Research Ethics Board at
the University of British Columbia approved this study.
Participants attended an orientation session followed by
a reflection period before signing the written informed
consent. Prior to all visits, participants were asked to
refrain from exhaustive exercise and alcohol for 24 h,
caffeine for 6 h, and food or non-water beverages for 2 h.
Each participant performed all trials at the same time of
day. Participants were also asked to maintain the same
pre-test routine including the same mode of travel to
the laboratory and pre-test meal, and were asked to re-
frain from vitamin supplementation for the duration of
the study. The sample size was calculated based on a
minimal detectable difference in FeNO of 2 ppb [25],
using an effect size of 0.37 (Cohen’s d), a power of 0.8,
and an alpha of 0.05.
Experimental design
Data collection for this study occurred as part of a larger
study and overall methods are explained in detail in other
publications [26, 27]. Briefly, each participant attended the
laboratory on seven occasions and the initial visit served
for familiarization and maximal exercise testing. On the
remaining testing days, participants performed 30-min
trials of low-intensity cycling, high-intensity cycling, or
rest. Each intensity, including rest, was performed once in
filtered air (FA) and once in DE with a target concentra-
tion of 300 μg/m3 of PM2.5, for a total of six trials, each of
which was separated by a 7-day period. Exercise intensity
and the exposure (FA and DE) were randomized with both
the participant and the researcher blinded to the exposure
condition and data suggests that individuals cannot deter-
mine whether they are exposed to DE or FA [28].
Introductory session (day 1)
For the maximal exercise test, the cycling work rate
started at 100W and increased by 0.5 W/s until vol-
itional exhaustion. To exclude those subjects with possible
exercise-induced bronchoconstriction, any individual with
a post-exercise decrease in forced expiratory volume in 1 s
(FEV1) by 10% or greater was excluded from the study.
Testing visits (days 2–7)
Testing visits 2–7 consisted of 30min trials of cycling or
30min of rest. Work rates on cycling days were based on
the peak power achieved during the maximal exercise test.
Low-intensity cycling was set at 30% of the power at
VO
•
2peak (96.1 (17.7) W) and high-intensity cycling was set
at 60% of power at VO
•
2peak (192.2 (35.3) W), which repre-
sented 48 and 77% of VO
•
2peak for low- and high-intensity
cycling respectively. Control exposures involved sitting for
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the same period (30min), but without performing exercise.
Pulmonary function, FeNO, heart rate variability (HRV),
plasma norepinephrine and symptoms were measured prior
to, immediately post, 1 h, and 2 h post-exposure. During
the post exercise/exposure period participants were in a
laboratory with normal environmental conditions.
Exercise apparatus
Exercise tests were performed using a Velotron cycle erg-
ometer (Racermate Inc., Seattle, WA, USA). During trials,
participants breathed through a facemask (7450 Series,
Hans Rudolph Inc., Kansas City, MO, USA) attached to
a low-resistance, non-rebreathing valve (NRB 2700, Hans
Rudolph Inc., Kansas City, MO, USA). Participants
remained outside the environmental booth but were con-
nected to the booth via 3.2 cm diameter hoses at both the
inspired and expired sides of the non-rebreathing valve.
Outcome measures
Heart rate variability
Following 20min of supine rest, heart rate was recorded
for five min in 15 participants in a quiet, dark room
(Polar S810, Polar Electro, Finland). Heart rate variability
was analyzed offline using custom software (Kubios
HRV, Kuopio, Finland). Time domain measures included
the standard deviation of normal-to-normal (NN) inter-
vals (SDNN), the root mean square of the mean differ-
ences in successive N-N intervals (RMSSD), and the
HRV triangular index. Frequency domain analysis was
performed using autoregressive modelling to determine
the spectral powers at low frequency (LF: 0.04–0.15
Hz) and high frequency (HF: 0.15–0.40 Hz) as well
as total power. Additionally, LF normalized units
(LFnu), HF normalized units (HFnu), and LF/HF ra-
tios were determined. Of the 360 measures of HRV
taken, seven were excluded due to a poor signal. To
prevent complete exclusion of those subjects with
missing measurements and based on the recommen-
dations of a statistician, the missing values were imputed
using regression [29].
FeNO
The FeNO was measured with a NIOX MINO® Airway
Inflammation Monitor (Aerocrine, Solna, Sweden), which
detects exhaled NO as an indicator of inflammation.
Measurements were performed as per the American
Thoracic Society guidelines [30]. Briefly, subjects inhaled to
close to total lung capacity and then exhaled at a flow
rate of 50 ml/s and a pressure of 10 cm H2O into the
device for 6 s. The device collected the expired gas
from the last 3 s of the exhalation to determine the
concentration of exhaled NO.
Pulmonary function
Pulmonary function was measured in 17 participants
using a portable spirometer (Spirobank G, Medical Inter-
national Research, Rome, Italy), as per the guidelines of
the American Thoracic Society [31]. Standard indices of
pulmonary function such as forced vital capacity (FVC),
FEV1, ratio of FVC to FEV1 (FEV1/FVC), forced expira-
tory flow during the mid-portion (25–75%) of an FVC
(FEF25–75) and peak expiratory flow rate (PEFR) were
measured. Participants performed three manoeuvres
(and up to a maximum of 6, if necessary) per testing
time point. For repeatability to be achieved, the differ-
ence between the highest and second highest trial for
FEV1 and FVC was required to fall within 0.15 L. The
peak value for each variable was used for analysis.
Plasma norepinephrine
Blood samples were taken from the right antecubital fossa
with a 21-gauge needle into vacutainers containing EDTA.
All blood samples were immediately centrifuged at 1500 g
for 20min to separate plasma from formed elements.
Plasma was extracted, frozen, and stored at − 80 °C until
assayed. Plasma concentrations of norepinephrine were
determined using commercially available enzyme-linked
immunosorbent assay (ELISA) kits (Norepinephrine
ELISA kit, Abnova, CA, USA) and according to the
procedures outlined by the manufacturer. Plasma levels
of norepinephrine were measured using aVersa Max micro-
plate reader (Molecular Devices Corporation, CA, USA).
The intra assay coefficient of variation for norepin-
ephrine was 7.1%.
Levels of norepinephrine were adjusted for changes in
plasma volume from baseline. The estimated post-exercise
concentration of markers due to plasma volume changes
alone was estimated using the following equation [32]:
ConcentrationESTIMATED ¼ HctPOST  100−HctPREð ÞHctPRE  100−HctPOSTð Þ  ConcentrationPRE
where Hct represents hematocrit. The adjusted concen-
tration was then calculated using the following equation:
ConcentrationADJUSTED ¼ ConcentrationPRE−ConcentrationESTIMATEDð Þ
þConcentrationMEASURED
Symptoms
At each time point, participants were asked to rate
symptoms on a scale of 0–5 with 0 being “no symptoms”
and 5 being “severe”. Participants were blinded to scores
from previous time points and test days. Symptoms were
grouped into eyes, nose, throat/chest and other and in-
cluded the following questions:
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Eye symptoms: Are your eyes itchy? Are your eyes
watering? Do you feel a painful or stinging sensation in
your eyes?
Nasal symptoms: Does your nose feel itchy? Do you
feel a painful or stinging sensation in your nose? Is your
nose running? Is your nose blocked? Are you sneezing?
Throat/Chest symptoms: Does your throat feel dry,
scratchy, or sore? Are you wheezing or do you have any
whistling sounds in your chest? Are you having any
chest pain? Are you having chest tightness? Do you have
shortness of breath?
Other symptoms: Do you have a headache? Do you feel
fatigued? Do you feel nauseous?
Within each category scores from individual questions
were summed to provide a score for nasal, eyes, throat/
chest and other. The symptoms chosen were those typic-
ally reported in similar studies which demonstrate that
participants are unable to determine if they are exposed
to DE or FA [28].
Exposure setup
All exposures were performed using an environmental ex-
posure booth that is explained in detail elsewhere [33],
but modified only in that load was constant at 2.5 kW. For
DE exposures, participants were exposed to calibrated,
aged, and diluted DE that had a target concentration
of 300 μg/m3 of PM2.5. In-booth PM mass concentra-
tion measurements were made using a Tapered Elem-
ent Oscillating Microbalance (TEOM; Model 1400a,
Rupprecht & Pattashnick, Albany, NY, USA) using 10
min averages. A TSI Scanning Mobility Particle Scan-
ner (Model 3936, TSI, Shoreview, MN, USA) classi-
fied the particle size distribution between 2.5 nm and
1000 nm. For FA exposures, participants were exposed to
compressed, HEPA-filtered air.
Statistical analysis
Statistical analyses were completed using SPSS software
(SPSS Inc., version 20, Chicago, IL) and analyses were
chosen through consultation with a PhD statistician. For
each parameter, data were analyzed using a 2 (exposure: FA
vs. DE) × 3 (intensity: rest, low-intensity, high-intensity) × 4
(time: pre, post, 1 h, 2 h) repeated measures ANOVA. Sig-
nificance was set at p < 0.05. Main or interaction effects
were further analyzed using pair-wise comparisons
and significance was adjusted to account for multiple
comparisons using the Sidak adjustment. The p-values
represented in this manuscript have been inflated to
incorporate the Sidak adjustment, meaning that α re-
mains at 0.05. Specifically, the Sidak adjustment uses
the following equation to adjust for multiple compari-
sons: 1- (1-unadjusted p-value)1/k, where k is the num-
ber of comparisons in the family. For the post-hoc analysis
comparing exercise intensity, p-values were adjusted for 3
groups (rest, low-intensity and high-intensity) and when
time was compared, p-values were adjusted for 4 groups
(pre, post, 1 h, 2 h). All means are reported with standard
deviations in parentheses.
Results
Eighteen recreationally active males (age 24.5 (6.2) yr. (mean
(sd)); height: 1.78 (0.08) m; body mass: 74.2 (10.5) kg)
completed the study. Their mean VO
•
2peak was 55.0 (9.1)
mL•kg− 1•min− 1, participants had a mean maximum power
output was 320.4 (58.9) W, and mean maximum heart rate
was 182.1 (12.7) bpm.
Baseline outcome variables were not significantly differ-
ent across the six test days (p > 0.05). All participants per-
formed all six trials, although three participants were
unable to finish the high-intensity trial in DE due to vol-
itional exhaustion. In individuals who were unable to fin-
ish the first high-intensity trial, the second high-intensity
exercise trial was designed to mimic the first; therefore,
the duration in trial two was reduced to match the first
trial. Exposure to PM2.5 was 9.3 (6.20) and 302.1
(6.50) μg/m3 for FA and DE respectively. Mean par-
ticle number concentration (PNC) during FA and DE
exposures were 0.14 × 104 and 61.60 × 104 (#/cm3).
Mean NO2 during FA and DE exposures was 0.04
(0.04) and 0.58 (0.15) ppm. Mean NO during FA and
DE exposures was 0.02 (0.02) and 7.00 (0.09) ppm.
Mean carbon monoxide during FA and DE exposures
was 3.00 (0.40) and 13.9 (2.10) ppm.
There was a significant intensity-by-time interaction for
all time and frequency domain indices of HRV (p < 0.05).
All indices except LF (nu) and LF/HF ratio signifi-
cantly decreased following high-intensity exercise. Im-
mediately post and 1 h post-exposure, these variables
were significantly lower following high-intensity exer-
cise compared to following rest. Conversely, compared
to baseline and to rest, LF (nu) and LF/HF ratio sig-
nificantly increased following high-intensity exercise
(Fig. 1). For detailed comparisons of significant differ-
ences see Additional files 1 and 2. There were no effects
of exposure condition on any indices of HRV.
There was a significant three-way interaction for FeNO
(exposure-by-intensity-by-time; p = 0.045, Fig. 2). Immedi-
ately following rest in FA, FeNO was significantly greater
than at 1 h post exposure (Fig. 2a. p = 0.025; 21.3 (2.2)
ppb vs. 19.6 (2.0) ppb). One hour following high-in-
tensity exercise in DE, FeNO was significantly greater
than pre-exercise (Fig. 2c. p = 0.024; 21.9 (2.4) ppb,
vs. 19.3 (2.2) ppb). Prior to high intensity exercise in
FA, FeNO was significantly less than immediately
post exposure (Fig. 2c. p = 0.048; 19.9 (1.4) ppb, vs.
22.7 (1.7) ppb); however, there were no differences
between FA and DE for any comparisons.
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Mean baseline FEV1 was 4.31 (0.76) L, FVC was 5.48
(1.13) L, FEV1/FVC was 0.79 (0.07), FEF25–75 4.00 (0.91)
L/s and PEFR was 9.79 (1.31) L/s. There was a signifi-
cant interaction effect for PEFR (exposure-by-intensity:
p = 0.036, Fig. 3a; intensity-by-time: p = 0.04, Fig. 3b). An
exposure-by-intensity interaction suggested that during
high-intensity exercise in FA, PEFR was significantly
greater than low-intensity exercise (Fig. 3a. p = 0.010; 9.93
(1.30) L/s vs. 9.52 (1.08) L/s) and rest (p = 0.017; 9.93
(1.30) L/s vs. 9.65 (1.24) L/s). However, this relationship
did not occur with DE. An intensity-by-time interaction
showed that immediately following high-intensity ex-
ercise PEFR was significantly greater than following
low-intensity exercise (Fig. 3b. p = 0.011; 9.95 (1.30) L/s
vs. 9.52 (1.11) L/s) and rest (p = 0.017; 9.95 (1.30) L/s vs.
9.57 (1.31) L/s). There were no other main or interaction
effects for FEV1, FVC or FEF25–75.
There was a significant interaction effect (intensity--
by-time: p < 0.001, Fig. 4) for plasma norepinephrine but
DE exposure did not modify this response. One hour
post low-intensity exercise norepinephrine levels were
significantly greater than prior to exercise (p = 0.015; 404.75
(34.43) pg•mL− 1 vs. 342.59 (25.24) pg•mL− 1). Prior to high
intensity exercise norepinephrine was significantly less than
immediately post (p = 0.003; 366.69 (29.81) pg•mL− 1
vs. 544.23 (39.25) pg•mL− 1) and 1 h post exercise
(p = 0.002; 366.69 (29.81) pg•mL− 1 vs. 504.16 (31.49)
pg•mL− 1). The elevation seen immediately post and 1 h
post high-intensity exercise meant that plasma norepineph-
rine levels at these time points were significantly greater
than 2 h post exercise (p = 0.007; post vs. 2 h: 544.23
(39.25) pg•mL− 1 vs. 421.71 (25.13) pg•mL− 1; p = 0.007;
1 h vs. 2 h: 504.16 (31.49) pg•mL− 1 vs. 421.71 (25.13)
pg•mL− 1). Norepinephrine was significantly greater
immediately post high-intensity exercise compared to
immediately post rest (p = 0.002; 544.23 (39.25) pg•mL− 1
vs. 370.10 (25.83) pg•mL− 1) and low-intensity exercise
(p < 0.001; 544.23 (39.25) pg•mL− 1 vs. 363.81 (26.31)
pg•mL− 1). Similarly, norepinephrine was significantly
greater 1 h following high-intensity exercise compared to
1 h post rest (p = 0.004; 504.16 (31.49) pg•mL− 1 vs. 375.17
(27.37) pg•mL− 1) and low-intensity exercise (p = 0.025;
504.16 (31.49) pg•mL− 1 vs. 404.76 (34.43) pg•mL− 1).
There was a significant interaction effect (condition--
by-time: p = 0.021, Fig. 5) for throat/chest symptoms.
Immediately following exposure to FA, symptoms for
the throat/chest were significantly greater than symp-
toms prior to exposure (p = 0.005; 1.06 (0.24) vs. 0.24
(0.07)), 1 h post exposure (p = 0.032; 1.06 (0.24) vs. 0.22,
(0.08)) and 2 h post exposure (p = 0.020; 1.06 (0.24) vs.
0.24 (0.08)). Similarly, immediately following exposure to
DE, symptoms for the throat/chest were significantly
Fig. 1 Heart rate variability (HRV) in 15 males prior to and following rest, low-intensity, or high-intensity cycling: (a) SDNN: Standard deviation of NN
intervals, (b) RMSSD: root mean square of successive intervals, (c) HRV triangular index, (d) Low frequency (LF) power, (e) High frequency (HF) power, (f)
Total power, (g) LF/HF, (h) LF power normalized units (nu), (i) HF power nu. A summary of significant differences can be found in Additional files 1 and 2
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greater than symptoms prior to exposure (p < 0.001; 1.74
(0.28) vs. 0.24 (0.07)), 1 h post exposure (p < 0.001; 1.74
(0.28) vs. 0.37 (0.10)) and 2 h post exposure (p = 0.001;
1.74 (0.28) vs. 0.37 (0.12)). However, the increase in
symptoms immediately following DE was significantly
greater following FA (p = 0.024; 1.74 (0.28) vs. 1.06 (0.24)).
There was also a significant intensity-by-time interaction
for eye symptoms (p = 0.042), nasal symptoms (p = 0.031),
throat/chest symptoms (p < 0.001) and other symptoms
(p < 0.001). Post hoc comparisons for eye symptoms
did not reveal significant differences. See Table 1 for
Post hoc comparisons for the intensity-by-time inter-
action for all categories of symptoms. The dataset sup-
porting the conclusions of this can be made available
upon request.
Discussion
This is the first study to determine the pulmonary and
autonomic nervous system effects of (DE) exposure with
exercise of varying intensities. We found that following
30min of exercise pulmonary function, FeNO, HRV, or
plasma norepinephrine were not significantly different
between low- and high-intensity exercise in DE. How-
ever, exposure to DE did exacerbate throat and chest
symptoms to a significantly greater degree than follow-
ing FA.
Particulate matter exposure causes oxidative stress, and
increases bronchial responsiveness, airway resistance, and
airway inflammatory cells [3, 4]. Following high-intensity
exercise in FA and DE (immediately post in FA and 1 h
post in DE) FeNO, which is a surrogate measure of airway
Fig. 2 FeNO prior to and following a rest, b low-intensity, or c high-intensity cycling in FA or DE. Significance is set at p < 0.05. β = significantly
greater than pre-exercise in the corresponding exposure, occurs only in DE (diesel exhaust) only; ϕ = significantly less than post in the
corresponding exposure (FA (filtered air) only)
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Fig. 3 a Exposure-by-intensity interaction and b intensity-by-time interaction for PEFR. Significance is set at p < 0.05. For the exposure-by-
intensity interaction data is collapsed across all time points and for the intensity-by-time interaction data is collapsed across both exposure
conditions. * Low-intensity (p = 0.011) and rest (p = 0.017) are significantly less than high-intensity exercise at the post-exercise time point
Fig. 4 Plasma norepinephrine in 18 males prior to and following rest, low-intensity cycling and high-intensity cycling. Significance is set at p < 0.05.
For the intensity-by-time interaction data is collapsed across both exposure conditions. * Significantly less than post in the corresponding exercise
intensity (high-intensity only). ** Significantly less than 1 h in the corresponding exercise intensity (high-intensity only). β Significantly greater in high-
intensity compared to low-intensity and rest. Φ Significantly less than 1 h in the corresponding exercise intensity (low-intensity only)
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inflammation, was significantly greater than compared to
baseline. The increase in FeNO was similar between DE
and FA, suggesting that DE did not magnify the response.
Therefore, these data suggest that in healthy individuals,
exercise in DE does not potentiate pulmonary inflamma-
tion as measured by FeNO; however, we cannot discount
that other markers of pulmonary inflammation, such as
eosinophils in sputum, have been affected. The lack of a
DE effect contradicts our initial hypothesis that DE expos-
ure would increase the amount of pulmonary inflamma-
tion post-exercise. Our findings are similar to others
showing that in healthy individuals, acute exercise/ phys-
ical activity in a high pollution/high traffic environment is
not associated with elevated FeNO [19, 34, 35]. Rundell et
al. assessed the FeNO response to 30min of cycling at
85–95% of maximum heart rate while Jacobs et al.
assessed the FeNO response to 20min of cycling at 74%
of maximum heart rate [19, 34]. The intensities used by
Rundell et al. and Jacobs et al. are similar to the high- and
low-intensity trials in the current study [19, 34] and fur-
ther corroborate our findings that exercise of varying in-
tensities with exposure to air pollution does not affect
FeNO. In this study we did not see acute changes in FeNO
with exposure to DE but it is possible that repeated expos-
ure during exercise/ physical activity is necessary to in-
crease FeNO. For example, Bos et al. [36] found that
individuals who aerobically trained in a polluted urban
environment had significantly elevated FeNO compared
to those aerobically training in a less polluted rural envir-
onment. The absence of a DE and FA difference could also
be due to post-exercise measurements occurring over too
short of a time frame or that that FeNO may not be a
stable or sensitive enough indicator of pulmonary inflam-
mation in healthy individuals.
Our finding suggesting that high-intensity exercise in-
creases FeNO, contrasts with work done by Verges et al.
who examined FeNO following 25min of incremental ex-
ercise (two 10min bouts at 46 and 60% of peak power,
followed by five min at 90% of peak power) [37]. Immedi-
ately following exercise, Verges et al. found that FeNO
significantly decreased [37]. Similarly, Evjenth et al. tested
FeNO following an 8min incremental test that reached
95% maximum heart rate [2] and found that immediately
Fig. 5 Sum of Throat and Chest symptoms prior to and following FA and DE. Significance set at 0 < 0.05. FA: Filtered air, DE: Diesel exhaust.
*Significantly less than post in the corresponding exposure (occurs in both DE and FA). ** DE significantly greater than FA at the same time point
Table 1 Mean (SD) for subjective symptoms in 18 recreationally
active males prior to and following exercise or rest
Rest Low-Intensity High-Intensity
Mean (SD) [95% CI]
Nasal Symptoms
Pre 0.33 (0.45) 0.22 (0.43)* 0.44 (0.48)
Post 0.42 (0.65)** 0.64 (0.76)* 1.08 (1.06)
1 h post 0.25 (0.39) 0.17 (0.30) 0.39 (0.63)*
2 h post 0.19 (0.31) 0.08 (0.26) * 0.17 (0.34)*
Throat/Chest Symptoms
Pre 0.28 (0.39)* 0.25 (0.43) * 0.14 (0.33) *
Post 0.81 (0.79)** 0.83 (0.66)** 2.56 (2.07)
1 h post 0.39 (0.47) 0.17 (0.34) * Φ 0.33 (0.42) *
2 h post 0.33 (0.42)* 0.31 (0.49) * 0.28 (0.39) *
Eye Symptoms
Pre 0.36 (0.17) 0.19 (0.11) 0.11 (0.09)
Post 0.17 (0.07) 0.22 (0.08) 0.50 (0.17)
1 h post 0.14 (0.08) 0.11 (0.09) 0.14 (0.07)
2 h post 0.08 (0.06) 0.06 (0.04) 0.11 (0.07)
Other Symptoms
Pre 0.19 (0.07) 0.22 (0.09) 0.14 (0.07)*
Post 0.47 (0.17)** 0.67 (0.17)* ** 2.11 (0.34)
1 h post 0.14 (0.07) ** 0.31 (0.11) 0.67 (0.23)*
2 h post 0.11 (0.07) ** 0.14 (0.05) 0.31 (0.09)*
*significantly less than post in the corresponding intensity, p < 0.05
**significantly less than high-intensity at the corresponding time point, p < 0.05
Φ significantly less than rest at the corresponding time point, p < 0.05
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following and 30min following exercise, FeNO levels were
significantly reduced [2]. Our results may be in opposition
to others [2, 37] due to the timeframe of sampling. In the
study by Verges et al., FeNO levels were returning towards
baseline 15min following exercise [37]. The measurement
of post-exercise FeNO in the current study occurred fol-
lowing a number of other physiological measures, which
meant that the post-exercise FeNO measurement could
have been measured up to 40min post-exercise. Therefore,
an immediate post-exercise reduction in FeNO could have
been missed in the current study. As exercise duration was
different between the current study and others [2, 37], it is
also possible that a different FeNO response was elicited.
In susceptible populations, PM-induced physiological
changes such as oxidative stress, bronchial hyperrespon-
siveness, and inflammation [3, 4] can result in impaired
lung function [38]. Within the current study, we found
that in FA, PEFR was significantly greater following
high-intensity exercise compared to rest. In DE, these
differences did not occur, leading to a trend for lower
PEFR in DE compared to FA. As the FA vs. DE differ-
ences were not significant, and there were no effects of
exposure on other parameters of pulmonary function,
one cannot conclude from this study that DE exposure
during exercise affects pulmonary function or that exer-
cise intensity magnifies this response. Our findings are
similar to those of others who found no associations be-
tween exposure to air pollution/PM and pulmonary
function following exercise or physical activity in urban
areas [18, 20, 35], and found that physical activity
reduced PM associated decrements in aspects of lung
function such as PEFR [6].
Immediately following DE exposure, throat and chest
symptoms were 0.68 points higher on a 5-point scale
compared to FA. Since the DE condition had such a high
concentration of PM2.5, these findings are not surprising.
It is interesting that in this healthy cohort, the participants
noticed more symptoms, yet the objective measures of
lung function and inflammation were not impacted.
While, DE exposure contains a mixture of particulate mat-
ter and gaseous pollutants, it is possible that we did not
observe differences in lung function and inflammation as
the mixture within the current study may differ from am-
bient conditions. Additionally, we may not have observed
significant differences based on the marker of pulmonary
inflammation chosen. FeNO is a surrogate measure of
eosinophilic airway inflammation and thus we cannot
discount that other aspects of airway inflammation were
impacted. Also, we cannot disregard that exercise dur-
ation, the time course of post exercise measures and the
fitness level or health status of our participants may have
led to non-significant findings. Finally, the sample size for
the current study was calculated based on a minimal
detectable difference in FeNO; therefore, it is possible that
other outcomes measures were not adequately statistically
powered.
One of the other potential pathways in which PM ex-
posure causes cardiovascular effects is through an increase
in sympathetic nervous system activity and a decrease in
parasympathetic nervous system activity demonstrating a
disruption in cardiac autonomic control [39]. Contrary to
our hypothesis, our research demonstrated that HRV is
not impacted by a controlled exposure to DE. This finding
is in accordance with other controlled experimental diesel
exposure studies [40, 41]. However, some epidemiological
research suggests that as PM2.5 [42] or PM10 [43, 44] con-
centrations increase, HRV is impaired (as demonstrated
by reductions in SDNN and RMSSD), yet there is still is a
lack of consensus on the magnitude, direction, and exist-
ence of an effect; as is demonstrated by some studies find-
ing a significant but positive association between PM and
SDNN [45] and others finding no association between PM
and indices of HRV [46]. Despite inconsistencies in the
literature, it appears that controlled diesel exposure
studies demonstrate a lack of an effect on HRV, while
observational and epidemiological studies are generally
conflicting. This discrepancy could be related to three
factors. DE does not contain metals found in atmos-
pheric air pollution such as nickel, lead, arsenic and
cadmium. These metals are thought to play a key role
in the autonomic nervous system response to air pollu-
tion [47]. A laboratory environment allows researchers
control of confounding factors and in this context does
not contain extraneous stressors, such as noise and
traffic, which may affect HRV. Finally, it is possible
that there could be a more long-term association be-
tween air pollution and HRV that is not captured in
the laboratory studies.
As highlighted, some PM exposure can cause an in-
crease in sympathetic nervous system activity and a
decrease in parasympathetic nervous system activity
[39]. As both the adrenal medulla and sympathetic nerve
endings produce norepinephrine, it is no surprise that
production of norepinephrine will increase in response
to sympathetic stimulation and potentially PM exposure.
Norepinephrine is produced by sympathetic nerve end-
ings and plays an important role in the pulmonary in-
flammatory response to PM exposure [48]. Therefore we
reasoned that any changes in HRV and FeNO would be
accompanied by changes in norepinephrine. We found
that plasma norepinephrine levels were significantly in-
creased following high intensity exercise, but there was
no difference in response between DE and FA. These
findings follow a similar pattern to the changes in FeNO
and HRV and are likely related to persistent sympathetic
activation following exercise/physical activity. The lack
of an effect of DE on norepinephrine is similar to other
human studies [49], but contrasts with human studies
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animal studies that found exposure to concentrated ambi-
ent particles increases norepinephrine in urine [50] and
the paraventricular nucleus of the hypothalamus [8]. As
with the HRV findings, the absence of effect of DE on
norepinephrine could be related to the constituents of the
pollution exposure, the time course of the study, or the
lack of extraneous stressors such as noise and traffic.
Conclusions
The current study assessed the acute pulmonary, auto-
nomic nervous system and symptomatic effects to 30min
of rest, low-, and high-intensity cycling with DE exposure
in healthy recreationally active males. We initially hypoth-
esized that DE would impair pulmonary function, cause
pulmonary inflammation, increase symptoms related to
DE exposure and result in autonomic responses that
would be magnified by exercise intensity; however, our
results do not support these hypotheses. Based on the re-
sults of this study, healthy individuals may experience an
increase in throat and chest symptoms with DE expos-
ure but exercising in DE does not magnify these. Add-
itionally, healthy individuals may not experience acute
pulmonary and autonomic effects from exercising in
DE. However, to substantiate this claim, more research
is needed to determine the effects of different compo-
sitions of air pollution over longer time frames during
exercise. Furthermore, these findings only apply to a
healthy, active population; further work in clinical
populations is necessary in order to understand the
combined effects of air pollution and exercise in these
groups.
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NE: Norepinephrine; NN: Normal-to-normal interval; NO: Nitric oxide;
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